Qiaoyang TENG
Professional Title: Associate Professor
Education: PhD
Supervisor Category: Master Supervisor
Research Fields: Pathogenic mechanisms of avian influenza viruses and the development of avian viral vaccines
一、Introduction
Teng Qiaoyang, Ph.D, associate professor, supervisor for master' s students. Her research focuses on the pathogenic mechanisms of avian influenza viruses and the development of avian viral vaccines. She has been successful in securing funding for her research, including a National Natural Science Foundation of China (NSFC) Youth Project, a Shanghai Natural Science Foundation project, and a key scientific and technological project from the Shanghai Municipal Science and Technology Commission. Additionally, she has received funding from central-level public welfare scientific research institutions and the Shanghai Talent Development Fund. As a sub-project leader, she has also obtained two projects from national key research and development programs and other national or provincial-level research projects.
Dr. Teng has made significant contributions to her field, with 40 papers published in domestic and international journals such as "J Virol," "Vet Microbiol," "PLoS One," and "J Virol Methods." Among these publications, she has served as the corresponding author or first author for 9 SCI papers. She has also written an industry standard and holds four national invention patents. Her research has led to the development of two new veterinary drugs (ranking third) and technology transfer valued at 27.6 million yuan.
二、Contact Information
Telephone：021-34293604
Email：tengqy@shvri.ac.cn
三、Representative Publications
1. Yan,WW; Cui, HR; Engelsma, M; Beerens, N; van Oers, MM; de Jong, MCM; Li, XS; Liu, QF; Yang, JM; Teng, QY*, Li, ZJ*. Molecular and Antigenic Characterization of Avian H9N2 Viruses in Southern China. Microbiol Spectr, 2022, 10(1): 0-e0082221.
2. Su X, Shuo D, Luo YQ, Pan X, Yan DW, Li XS, Lin WS, Huang DM, Yang JM, Yuan CX, Liu QF, Teng QY*, and Li ZJ*. An Emerging Duck Egg-Reducing Syndrome Caused by a Novel Picornavirus Containing Seven Putative 2A Peptides. Viruses, 2022, 14(5):932.
3. Teng QY,Xu DW, Shen WX, Liu QF, Rong GY, Li XS, Yan LP, Yang JM, Chen HJ, Yu H, Ma WJ* , Li ZJ*. A Single Mutation at Position 190 in Hemagglutinin Enhances Binding Affinity for Human Type Sialic Acid Receptor and Replication of H9N2 Avian Influenza Virus in Mice. J Virol, 2016,90(21): 9806-9825.
4. Lin W, Cui H, Teng Q, Li L, Shi Y, Li X, Yang J, Liu Q, Deng J,Li Z.Evolution and pathogenicity of H6 avian influenza viruses isolated from Southern China during 2011 to 2017 in mice and chickens.Sci Rep,2020,25;10(1),2045-2322.
5. Teng QY, Shen WX, Yan DW, Yan LP, Li XS, Li GX, Yang JM, Li ZJ*. Development of a TaqMan MGB RT-PCR for the rapid detection of H3 subtype avian influenza virus circulating in China. J Virol Methods, 2015,217:64-9.
6. Teng QY, Shen WX, Liu QF, Rong GY, Chen L, Li XS, Chen HJ, Yang JM, Li ZJ* (2015). Protective efficacy of an inactivated vaccine against H9N2 avian influenza virus in ducks.2015. Virol J.12:143.
7. Teng QY, Hu T, Li XS, Li GX, Li ZJ* (2012). Complete Genome Sequence of an H3N2 Avian Influenza Virus Isolated from a Live Poultry Market in Eastern China. J Virol, 86: 11944.
8. Teng QY, Zhang X, Xu DW, Zhou JW, Dai XG, Chen ZG, Li ZJ*(2013). Characterization of an H3N2 canine influenza virus isolated from Tibetan mastiffs in China.Vet Microbiol.162(2-4):345-352.
9. Teng QY, Ji XW, Li GX, Li XS, Li ZJ *(2012). Complete Genome Sequences of a Novel Reassortant H4N2 Avian Influenza Virus Isolated from a Live Poultry Market in Eastern China. J Virol. 86:11952.
10. Wang S, Teng QY, Jia L, Sun X, Wu Y, Zhou J*(2014). Infectious bursal disease virus influences the transcription of chicken γc and γc family cytokines during infection. PLoS One. 2014.9;9(1):e84503.( co-first author)
四、Granted national invention patents
1. Recombinant Canine Influenza Virus and its Preparation Method and Application, 2012, China, Patent number: ZL201110139528.3.
2. MDCK Cell Line Stable Expressing Highly Pathogenic Avian Influenza Virus HA Protein and its Use, 2013, China, Patent number: ZL201010106774.4.
3. Duck Hepatitis Virus, Vaccine, and Detection Kit, 2014, China, Patent number: ZL20100601050.7.
4. Attenuated Strain of Duck Tembusu Virus and its Application, 2015, China, Patent number: ZL201210279232.6.
五、Standards
1. Agricultural industry standard: “Technical Guidelines for Diagnosis of Duck Tembusu Virus Disease” (NY/T 3233-2018),2018, ranked fifth.
六、Awarded Achievements
1．National New Veterinary Drug Registration Certificate, Duck Tembusu Virus Live Vaccine (Strain FX2010-180P), Certificate Number: (2018) New Veterinary Drug Certificate No. 41, 2018, ranked third.
2. National New Veterinary Drug Registration Certificate, Duck Tembusu Virus ELISA Antibody Test Kit, Certificate Number: (2021) New Veterinary Drug Certificate No. 45, 2021, ranked third.